Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmetoxy coumarin) of platelet aggregation in dog stenosed coronary artery

M. Prosdocimi, M. Finesso, F. Tessari, A. Gorio, L. R. Languino, G. de Gaetano, E. Dejana

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The action of ADA as an anti-thrombotic agent was studied in a model of coronary artery thrombosis and on platelet aggregation in the dog. AD6 (10 - 100 pM) in vitro inhibited aggregation induced by ADP, epinephrine, collagen and PAF (platelet aggregating factor) used at their threshold concentration for maximal aggregation. Arterial thrombosis was induced in a coronary vessel by critically reducing (about 70%) the vessel lumen. Thrombus formation was estimated by measuring coronary flow in the stenosed vessel. Using this procedure on the left descending coronary artery (LAD), we obtained reproducible blood flow changes in 18 dogs. AD6was given i.v. at three different doses. At 0.25 mg/kg two out of four dogs showed decreased thrombus formation at the stenosis site. Seven out of eleven dogs treated with 0.5 mg/kg and two out of three treated with 1.5 mg/kg showed decreased thrombus formation. Major decreases in coronary resistance, evaluated by measuring blood flow in the unstenosed left circumflex artery (LCX), were evident only after the highest dose. We conclude that AD6 has an inhibitory action on dog platelet aggregation and reduces thrombus formation in a stenosed coronary vessel.

Original languageEnglish
Pages (from-to)399-409
Number of pages11
JournalThrombosis Research
Volume39
Issue number4
DOIs
Publication statusPublished - Aug 15 1985

Fingerprint

Platelet Aggregation
Coronary Vessels
Thrombosis
Dogs
Coronary Thrombosis
Platelet Activating Factor
Adenosine Diphosphate
Epinephrine
Pathologic Constriction
Collagen
Arteries
cloricromen
coumarin 7

Keywords

  • AD
  • coronary artery stenosis
  • dog
  • Platelet aggregation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmetoxy coumarin) of platelet aggregation in dog stenosed coronary artery. / Prosdocimi, M.; Finesso, M.; Tessari, F.; Gorio, A.; Languino, L. R.; de Gaetano, G.; Dejana, E.

In: Thrombosis Research, Vol. 39, No. 4, 15.08.1985, p. 399-409.

Research output: Contribution to journalArticle

Prosdocimi, M. ; Finesso, M. ; Tessari, F. ; Gorio, A. ; Languino, L. R. ; de Gaetano, G. ; Dejana, E. / Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmetoxy coumarin) of platelet aggregation in dog stenosed coronary artery. In: Thrombosis Research. 1985 ; Vol. 39, No. 4. pp. 399-409.
@article{e63ee66b85784eae8b3e61d976b39edf,
title = "Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmetoxy coumarin) of platelet aggregation in dog stenosed coronary artery",
abstract = "The action of ADA as an anti-thrombotic agent was studied in a model of coronary artery thrombosis and on platelet aggregation in the dog. AD6 (10 - 100 pM) in vitro inhibited aggregation induced by ADP, epinephrine, collagen and PAF (platelet aggregating factor) used at their threshold concentration for maximal aggregation. Arterial thrombosis was induced in a coronary vessel by critically reducing (about 70{\%}) the vessel lumen. Thrombus formation was estimated by measuring coronary flow in the stenosed vessel. Using this procedure on the left descending coronary artery (LAD), we obtained reproducible blood flow changes in 18 dogs. AD6was given i.v. at three different doses. At 0.25 mg/kg two out of four dogs showed decreased thrombus formation at the stenosis site. Seven out of eleven dogs treated with 0.5 mg/kg and two out of three treated with 1.5 mg/kg showed decreased thrombus formation. Major decreases in coronary resistance, evaluated by measuring blood flow in the unstenosed left circumflex artery (LCX), were evident only after the highest dose. We conclude that AD6 has an inhibitory action on dog platelet aggregation and reduces thrombus formation in a stenosed coronary vessel.",
keywords = "AD, coronary artery stenosis, dog, Platelet aggregation",
author = "M. Prosdocimi and M. Finesso and F. Tessari and A. Gorio and Languino, {L. R.} and {de Gaetano}, G. and E. Dejana",
year = "1985",
month = "8",
day = "15",
doi = "10.1016/0049-3848(85)90163-X",
language = "English",
volume = "39",
pages = "399--409",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmetoxy coumarin) of platelet aggregation in dog stenosed coronary artery

AU - Prosdocimi, M.

AU - Finesso, M.

AU - Tessari, F.

AU - Gorio, A.

AU - Languino, L. R.

AU - de Gaetano, G.

AU - Dejana, E.

PY - 1985/8/15

Y1 - 1985/8/15

N2 - The action of ADA as an anti-thrombotic agent was studied in a model of coronary artery thrombosis and on platelet aggregation in the dog. AD6 (10 - 100 pM) in vitro inhibited aggregation induced by ADP, epinephrine, collagen and PAF (platelet aggregating factor) used at their threshold concentration for maximal aggregation. Arterial thrombosis was induced in a coronary vessel by critically reducing (about 70%) the vessel lumen. Thrombus formation was estimated by measuring coronary flow in the stenosed vessel. Using this procedure on the left descending coronary artery (LAD), we obtained reproducible blood flow changes in 18 dogs. AD6was given i.v. at three different doses. At 0.25 mg/kg two out of four dogs showed decreased thrombus formation at the stenosis site. Seven out of eleven dogs treated with 0.5 mg/kg and two out of three treated with 1.5 mg/kg showed decreased thrombus formation. Major decreases in coronary resistance, evaluated by measuring blood flow in the unstenosed left circumflex artery (LCX), were evident only after the highest dose. We conclude that AD6 has an inhibitory action on dog platelet aggregation and reduces thrombus formation in a stenosed coronary vessel.

AB - The action of ADA as an anti-thrombotic agent was studied in a model of coronary artery thrombosis and on platelet aggregation in the dog. AD6 (10 - 100 pM) in vitro inhibited aggregation induced by ADP, epinephrine, collagen and PAF (platelet aggregating factor) used at their threshold concentration for maximal aggregation. Arterial thrombosis was induced in a coronary vessel by critically reducing (about 70%) the vessel lumen. Thrombus formation was estimated by measuring coronary flow in the stenosed vessel. Using this procedure on the left descending coronary artery (LAD), we obtained reproducible blood flow changes in 18 dogs. AD6was given i.v. at three different doses. At 0.25 mg/kg two out of four dogs showed decreased thrombus formation at the stenosis site. Seven out of eleven dogs treated with 0.5 mg/kg and two out of three treated with 1.5 mg/kg showed decreased thrombus formation. Major decreases in coronary resistance, evaluated by measuring blood flow in the unstenosed left circumflex artery (LCX), were evident only after the highest dose. We conclude that AD6 has an inhibitory action on dog platelet aggregation and reduces thrombus formation in a stenosed coronary vessel.

KW - AD

KW - coronary artery stenosis

KW - dog

KW - Platelet aggregation

UR - http://www.scopus.com/inward/record.url?scp=0022271238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022271238&partnerID=8YFLogxK

U2 - 10.1016/0049-3848(85)90163-X

DO - 10.1016/0049-3848(85)90163-X

M3 - Article

C2 - 3840290

AN - SCOPUS:0022271238

VL - 39

SP - 399

EP - 409

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 4

ER -